These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 17883392)

  • 1. The effects of oxidative stress on parkin and other E3 ligases.
    LaVoie MJ; Cortese GP; Ostaszewski BL; Schlossmacher MG
    J Neurochem; 2007 Dec; 103(6):2354-68. PubMed ID: 17883392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis.
    Jiang H; Ren Y; Zhao J; Feng J
    Hum Mol Genet; 2004 Aug; 13(16):1745-54. PubMed ID: 15198987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkin is protective for substantia nigra dopamine neurons in a tau gene transfer neurodegeneration model.
    Klein RL; Dayton RD; Henderson KM; Petrucelli L
    Neurosci Lett; 2006 Jun; 401(1-2):130-5. PubMed ID: 16554120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of proteasomal activity causes inclusion formation in neuronal and non-neuronal cells overexpressing Parkin.
    Ardley HC; Scott GB; Rose SA; Tan NG; Markham AF; Robinson PA
    Mol Biol Cell; 2003 Nov; 14(11):4541-56. PubMed ID: 12937272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine covalently modifies and functionally inactivates parkin.
    LaVoie MJ; Ostaszewski BL; Weihofen A; Schlossmacher MG; Selkoe DJ
    Nat Med; 2005 Nov; 11(11):1214-21. PubMed ID: 16227987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial artificial chromosome transgenic mice expressing a truncated mutant parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant alpha-synuclein.
    Lu XH; Fleming SM; Meurers B; Ackerson LC; Mortazavi F; Lo V; Hernandez D; Sulzer D; Jackson GR; Maidment NT; Chesselet MF; Yang XW
    J Neurosci; 2009 Feb; 29(7):1962-76. PubMed ID: 19228951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkin and defective ubiquitination in Parkinson's disease.
    Dawson TM
    J Neural Transm Suppl; 2006; (70):209-13. PubMed ID: 17017531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress.
    Moore DJ; Zhang L; Troncoso J; Lee MK; Hattori N; Mizuno Y; Dawson TM; Dawson VL
    Hum Mol Genet; 2005 Jan; 14(1):71-84. PubMed ID: 15525661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons.
    Petrucelli L; O'Farrell C; Lockhart PJ; Baptista M; Kehoe K; Vink L; Choi P; Wolozin B; Farrer M; Hardy J; Cookson MR
    Neuron; 2002 Dec; 36(6):1007-19. PubMed ID: 12495618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson's disease.
    Yasuda T; Mochizuki H
    Apoptosis; 2010 Nov; 15(11):1312-21. PubMed ID: 20221696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detrimental effects of oxidative losses in parkin activity in a model of sporadic Parkinson's disease are attenuated by restoration of PGC1alpha.
    Siddiqui A; Rane A; Rajagopalan S; Chinta SJ; Andersen JK
    Neurobiol Dis; 2016 Sep; 93():115-20. PubMed ID: 27185595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkin promotes proteasomal degradation of p62: implication of selective vulnerability of neuronal cells in the pathogenesis of Parkinson's disease.
    Song P; Li S; Wu H; Gao R; Rao G; Wang D; Chen Z; Ma B; Wang H; Sui N; Deng H; Zhang Z; Tang T; Tan Z; Han Z; Lu T; Zhu Y; Chen Q
    Protein Cell; 2016 Feb; 7(2):114-29. PubMed ID: 26746706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease.
    Shimura H; Schlossmacher MG; Hattori N; Frosch MP; Trockenbacher A; Schneider R; Mizuno Y; Kosik KS; Selkoe DJ
    Science; 2001 Jul; 293(5528):263-9. PubMed ID: 11431533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of Parkin by the cyclin-dependent kinase 5 at the linker region modulates its ubiquitin-ligase activity and aggregation.
    Avraham E; Rott R; Liani E; Szargel R; Engelender S
    J Biol Chem; 2007 Apr; 282(17):12842-50. PubMed ID: 17327227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease.
    Ardley HC; Scott GB; Rose SA; Tan NG; Robinson PA
    J Neurochem; 2004 Jul; 90(2):379-91. PubMed ID: 15228595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of parkin in Parkinson's disease].
    Miklya I; Göltl P; Hafenscher F; Pencz N
    Neuropsychopharmacol Hung; 2014 Jun; 16(2):67-76. PubMed ID: 24978049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Programmed cell death-2 isoform1 is ubiquitinated by parkin and increased in the substantia nigra of patients with autosomal recessive Parkinson's disease.
    Fukae J; Sato S; Shiba K; Sato K; Mori H; Sharp PA; Mizuno Y; Hattori N
    FEBS Lett; 2009 Feb; 583(3):521-5. PubMed ID: 19146857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function.
    Ko HS; Lee Y; Shin JH; Karuppagounder SS; Gadad BS; Koleske AJ; Pletnikova O; Troncoso JC; Dawson VL; Dawson TM
    Proc Natl Acad Sci U S A; 2010 Sep; 107(38):16691-6. PubMed ID: 20823226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The C289G and C418R missense mutations cause rapid sequestration of human Parkin into insoluble aggregates.
    Gu WJ; Corti O; Araujo F; Hampe C; Jacquier S; Lücking CB; Abbas N; Duyckaerts C; Rooney T; Pradier L; Ruberg M; Brice A
    Neurobiol Dis; 2003 Dec; 14(3):357-64. PubMed ID: 14678753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.